Author:
Movaghar Rouhina,Abbasalizadeh Shamci,Vazifekhah Shabnam,Farshbaf-Khalili Azizeh,Shahnazi Mahnaz
Abstract
Abstract
Introduction
Preeclampsia affects a significant percentage of pregnancies which is a leading cause of premature birth. Probiotics have the potential to affect inflammatory factors, and oxidative stress, which are linked to the development of preeclampsia. The study aimed to compare the effect of synbiotic and placebo on blood pressure and pregnancy duration as primary outcomes, and other pregnancy outcomes.
Methods
This study comprised 128 pregnant women with mild preeclampsia and gestational ages exceeding 24 weeks who were referred to the high-risk pregnancy clinic. It was a randomized, controlled, phase III, triple-blinded clinical experiment. The intervention and control groups were distributed to the participants at random. Intervention group received one oral synbiotic capsule, and control group received placebo daily until delivery. Based on gestational age at the time of diagnosis, preeclampsia was stratificated as early (< 34 weeks) or late (≥ 34 weeks). Data obtained from questionnaires, and biochemical serum factors were analyzed using SPSS software version 23 software.
Results
With the exception of the history of taking vitamin D3, there were no statistically significant variations in socio-demographic variables between the research groups. After the intervention, the means of systolic blood pressure (adjusted mean difference: -13.54, 95% CI: -5.01 to -22.07), and diastolic blood pressure (adjusted mean difference: -10.30, 95% CI: -4.70 to -15.90) were significantly lower in the synbiotic-supplemented group than in the placebo group. Compared to the placebo group, the incidence of severe PE (p < 0.001), proteinuria (p = 0.044), and mean serum creatinine level (p = 0.005) significantly declined in the synbiotic-supplemented group after the intervention. However, our analysis found no significant association for other outcomes.
Conclusion
Based on our results, synbiotic had beneficial effects on some pregnancy outcomes. Further studies with larger samples are needed to verify the advantages of synbiotic supplementation for high-risk pregnancies, particularly with regards to higher doses, and longer intervention periods.
Trial registration
IRCT20110606006709N20.
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,Reproductive Medicine,General Medicine
Reference75 articles.
1. Bennett P, Williamson C, Sykes L, MacIntyre DA, Dixon PH. Basic Science in Obstetrics and Gynaecology E-Book: A Textbook for MRCOG Part 1. Elsevier Health Sciences; 2022.
2. Harlow FH, Brown MA. The diversity of diagnoses of preeclampsia. Hypertens Pregnancy. 2001;20(1):57–67.
3. Leeman L, Fontaine P. Hypertensive disorders of pregnancy. Am Family Phys. 2008;78(1):93–100.
4. Duley L, editor. Editor the global impact of pre-eclampsia and eclampsia. Seminars in perinatology. Elsevier; 2009.
5. Kharaghani R, Cheraghi Z, Esfahani BO, Mohammadian Z, Nooreldinc RS. Prevalence of preeclampsia and eclampsia in Iran. Arch Iran Med. 2016;19(1):0.